Drug class
Venotonic and capillary-protective agent; flavonoid-related vasoprotective compound
Mechanism of action
Reported to reduce capillary permeability and fragility and to influence venous tone and microcirculatory function. Its precise molecular mechanism and clinical contribution are not fully established.
General use cases
- Historically used for symptoms associated with chronic venous insufficiency and capillary fragility in countries where naftazone is authorised; current availability and evidence vary by jurisdiction.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
